Home  »  Companies   »  PRA Health Sciences Inc. (PRAH) Review – Mak...

PRA Health Sciences Inc. (PRAH) Review – Making Smarter Decisions

427 institutions hold shares in PRA Health Sciences Inc. (PRAH), with 152.32k shares held by insiders accounting for 0.24% while institutional investors hold 94.01% of the company’s shares. The shares outstanding are 64.54M, and float is at 64.37M with Short Float at 3.36%. Institutions hold 93.79% of the Float.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Price (T.Rowe) Associates Inc with over 7.05 million shares valued at $884.96 million. The investor’s holdings represent 10.93% of the PRAH Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 6.71 million shares valued at $841.59 million to account for 10.39% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.42 million shares representing 9.95% and valued at over $805.87 million, while Massachusetts Financial Services Co. holds 9.48% of the shares totaling 6.12 million with a market value of $767.2 million.

PRA Health Sciences Inc. (NASDAQ: PRAH) is 32.41% higher on its value in year-to-date trading and has touched a low of $85.45 and a high of $167.41 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRAH stock was last observed hovering at around $166.19 in the last trading session, with the day’s loss setting it -0.1% off its average median price target of $159.50 for the next 12 months. It is also 15.26% off the consensus price target high of $196.00 offered by 10 analysts, but current levels are -7.15% lower than the price target low of $155.00 for the same period.

Currently trading at $166.09, the stock is 4.07% and 10.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.77 million and changing -0.06% at the moment leaves the stock 37.34% off its SMA200. PRAH registered 84.14% gain for a year compared to 6-month gain of 55.57%. The firm has a 50-day simple moving average (SMA 50) of $154.81 and a 200-day simple moving average (SMA200) of $129.17.

The stock witnessed a 9.24% loss in the last 1 month and extending the period to 3 months gives it a 36.30%, and is 1.24% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.13% over the week and 1.46% over the month.

PRA Health Sciences Inc. (PRAH) has around 18100 employees, a market worth around $10.59B and $3.18B in sales. Current P/E ratio is 54.67 and Fwd P/E is 24.96. Profit margin for the company is 6.20%. Distance from 52-week low is 94.37% and -0.79% from its 52-week high. The company has generated returns on investments over the last 12 months (9.60%).

PRA Health Sciences Inc. (PRAH) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for PRA Health Sciences Inc. (PRAH) is a “Hold”. 10 analysts offering their recommendations for the stock have an average rating of 2.80, where 8 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

PRA Health Sciences Inc. is expected to release its quarterly report on 08/11/2021 and quarterly earnings per share for the current quarter are estimated at $1.34 with sales reaching $933.77M over the same period.The EPS is expected to shrink by -17.40% this year, but quarterly earnings will post 12.20% year-over-year. Quarterly sales are estimated to grow 19.10% in year-over-year returns.

PRA Health Sciences Inc. (PRAH) Insider Activity

A total of 3 insider transactions have happened at PRA Health Sciences Inc. (PRAH) in the last six months, with sales accounting for 2 and purchases happening 1 times. The most recent transaction is an insider sale by Bonello Michael J., the company’s EVP & CFO. SEC filings show that Bonello Michael J. sold 2,048 shares of the company’s common stock on Apr 26 at a price of $166.77 per share for a total of $0.34 million. Following the sale, the insider now owns 19228.0 shares.

PRA Health Sciences Inc. disclosed in a document filed with the SEC on Jan 08 that Gaenzle Christopher L (EVP, CAO & General Counsel) sold a total of 3,136 shares of the company’s common stock. The trade occurred on Jan 08 and was made at $130.04 per share for $0.41 million. Following the transaction, the insider now directly holds 34500.0 shares of the PRAH stock.

Still, SEC filings show that on Dec 17, Bonello Michael J. (EVP & CFO) disposed off 33,372 shares at an average price of $120.12 for $4.01 million. The insider now directly holds 21,276 shares of PRA Health Sciences Inc. (PRAH).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

PRA Health Sciences Inc. (PRAH): Who are the competitors?

The company’s main competitors (and peers) include Flexion Therapeutics Inc. (FLXN) that is trading -18.83% down over the past 12 months. Short interest in the company’s stock has fallen -94.59% from the last report on Apr 14, 2021 to stand at a total of 2.16 million short shares sold with a short interest ratio of 2.52.

Related Posts




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam